- Article
Background: Metabolic syndrome (MetS) is a complex systemic disorder involving metabolic dysfunction, chronic low-grade inflammation, and increased cardiovascular risk. Hematological alterations may reflect these systemic disturbances and could provide easily accessible markers of disease progression and response to intervention. This study investigated the effects of a high-fat diet (HFD) and subsequent calorie restriction (CR) on hematological parameters and derived inflammatory indices while exploring the potential involvement of AMP-activated protein kinase (AMPK) signaling. Methods: Eight-week-old male Wistar-Kyoto rats were divided into four groups (n = 9–10/group): CTRL, standard diet for 10 weeks; HFD, 42% high-fat diet for 10 weeks; HFD-CR, 6 weeks of HFD followed by 4 weeks of CR (20% for 2 weeks and 35% for last 2 weeks); and HFD-CR-CC, the same HFD-CR protocol combined with Compound C (1.5 mg/kg, i.p., twice weekly during CR) to inhibit AMPK. Metabolic and biometric parameters, as well as complete blood count (CBC), were recorded. Derived inflammatory indices were calculated from CBC values. Results: HFD induced metabolic alterations accompanied by CBC changes including changes in leukocyte profiles, decreased erythrocyte parameters (erythrocyte count, hematocrit, and hemoglobin concentration), and altered platelet indices. CR reversed some of these changes. AMPK inhibition during CR decreased the proportion of lymphocytes, increased neutrophil counts, and elevated derived inflammatory indices. Conclusions: Results suggest that routine hematological indices may serve as accessible markers of metabolic dysfunction and response to dietary intervention. AMPK may contribute to CR-induced changes in leukocyte profiles. Further investigation of hematological markers might enable earlier diagnosis and more personalized management of MetS.
21 November 2026




![Schematic showing how MNPs, plastic-associated EDCs, tire wear particles/6PPD-quinone, and gut microbiome disturbance converge on disrupted neurodevelopment. Adapted from our previous schematic [20] and updated with the present findings. Solid arrows indicate hypothesized exposure-driven pathways, and the dashed arrow indicates genetic or immune modifiers that may interact with exposure; no arrow implies an established causal relationship in humans. Abbreviations: 6PPD-Q, 6PPD-quinone; ASD, autism spectrum disorder; CYP19A1, cytochrome P450 family 19 subfamily A member 1 (aromatase gene); EDCs, endocrine-disrupting chemicals; FRα, folate receptor alpha; MTHFR, methylenetetrahydrofolate reductase; NF-κB, nuclear factor kappa-light-chain-enhancer of activated B cells; RARα, retinoic acid receptor alpha; RXRα, retinoid X receptor alpha; SCFA, short-chain fatty acid; TBR1, T-box brain protein 1; TLR4, Toll-like receptor 4; ↑, increased; ↓, decreased.](https://mdpi-res.com/pathophysiology/pathophysiology-33-00090/article_deploy/html/images/pathophysiology-33-00090-g001-550.jpg)




![Glucose-dependent regulation of intracellular insulin degradation and lysosomal subpopulations in pancreatic β-cells. Schematic representation of the relationship between extracellular glucose concentration, intracellular insulin degradation, and lysosomal composition in β-cells. At low glucose (3.3 mM), intracellular degradation is elevated and the lysosomal compartment is enriched in insulin-negative secondary lysosomes, consistent with increased autophagic activity. At physiological glucose (5.5 mM), crinophagic degradation of insulin granules is maximal, reflecting accumulation of newly synthesized granules that exceed secretory demand. At high glucose (28 mM), insulin degradation is minimized as granules are preferentially released by exocytosis, resulting in a predominance of primary lysosomes and reduced crinophagic activity. The lower panel outlines key molecular regulators, where blue down arrows and red up arrows indicate decreased and increased pathway activity. Adapted from morphometric analyses of mouse islets reported by Pasquier et al. and Borg & Schnell [4,18].](https://mdpi-res.com/pathophysiology/pathophysiology-33-00045/article_deploy/html/images/pathophysiology-33-00045-g001-550.jpg)